FDA Clearance Tracker · P970004-S390
InterStim Therapy System, Verify Evaluation System
Last checked: Nov 20, 2026Latest source record: Dec 18, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Dec 18, 2023
Approved
Time to decision
81 days
Received Sep 28, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P970004-S390
- Device name
- InterStim Therapy System, Verify Evaluation System
- Applicant
- Medtronic Neuromodulation
- Applicant location
- Minneapolis, MN
- Received
- Sep 28, 2023
- Decided
- Dec 18, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P970004
Device type
- Device class
- Class III
- Regulation
- 21 CFR 876.5270
FDA's approval statement
As written in FDA's record.
for labeling updates to the MRI Guidelines manual. The proposed labeling updates are to add the following: 1. MRI eligibility (full-body scans at 1.5T, 3T) criteria for abandoned lead fragments that may remain behind when explant is attempted. 2. MRI eligibility (head-only scans at 1.5T) criteria for a confirmed non-functional primary cell (non-rechargeable) implantable neurostimulator from Medtronic
Source documents
Other decisions for Medtronic Neuromodulation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P240011 · Decided Sep 18, 2025 · 532 days after receipt
Device type: Stimulator, tibial, electrical, implantable, for urinary incontinence (QPT) · GI, Urology & Nephrology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.